Investigational Site Number :3800006

Meldola, Forlì-Cesena 47014

0 studies enrolling now · 1 studies all time

What they study most

Plasma Cell Myeloma

Studies at this site

• Isatuximab in Combination With Lenalidomide and Dexamethasone in High-risk Smoldering Multiple Myeloma — Running, not enrolling